| scholarly article | Q13442814 |
| P2093 | author name string | Börte Gürbüz Özgür | |
| Hatice Aksu | |||
| Sevcan Karakoç Demirkaya | |||
| P2860 | cites work | Clinical interventions for treatment non-adherence in psychosis: meta-analysis | Q28204404 |
| Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management | Q28236854 | ||
| Parent management training: evidence, outcomes, and issues | Q28251663 | ||
| Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
| The clinical global impressions scale: applying a research tool in clinical practice | Q33894649 | ||
| Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. | Q33960193 | ||
| Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients. | Q50456515 | ||
| Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood. | Q51927832 | ||
| Very early predictors of conduct problems and crime: results from a national cohort study. | Q52296872 | ||
| Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder | Q95801819 | ||
| ??? | Q26849779 | ||
| A quasi-experimental analysis of the association between family income and offspring conduct problems | Q34102933 | ||
| Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options | Q34109632 | ||
| The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being | Q34126803 | ||
| Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. American Academy of Child and Adolescent Psychiatry | Q34442712 | ||
| The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder | Q34529904 | ||
| Risperidone in the treatment of conduct disorder in preschool children without intellectual disability | Q34995022 | ||
| Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder | Q35486056 | ||
| A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder | Q35965634 | ||
| Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents | Q36597394 | ||
| Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. | Q36949869 | ||
| Six-month open-label follow-up of risperidone long-acting injection use in pediatric bipolar disorder | Q37226984 | ||
| Long Acting Risperidone in an Adolescent with Conduct Disorder: A Case Report | Q37299991 | ||
| Review of medication adherence in children and adults with ADHD. | Q37682563 | ||
| What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? | Q37699333 | ||
| Long-acting Injectable Risperidone Use in an 11-Years-Old Bipolar Child | Q37703769 | ||
| Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. | Q37761734 | ||
| The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. | Q38180497 | ||
| Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders | Q38735633 | ||
| Prevalence and development of psychiatric disorders in childhood and adolescence | Q39605940 | ||
| Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection | Q39659500 | ||
| Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies | Q42610208 | ||
| Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. | Q42623849 | ||
| An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder | Q43287181 | ||
| Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. | Q43704794 | ||
| Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. | Q44121248 | ||
| Female and male antisocial trajectories: from childhood origins to adult outcomes. | Q46006926 | ||
| Use of risperidone long-acting injection to support treatment adherence and mood stabilization in pediatric bipolar patients: a case series. | Q46031894 | ||
| A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone | Q46495720 | ||
| Olanzapine treatment in adolescents with severe conduct disorder | Q46951783 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | risperidone | Q412443 |
| conduct disorder | Q596474 | ||
| adherence (medicine) | Q67004728 | ||
| P304 | page(s) | 328-336 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | Q26842559 |
| P1476 | title | A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder | |
| P478 | volume | 15 |
Search more.